Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Britain has elected the most LGBTI MPs in the world

With the final votes counted and the General Election over, Britain is officially the country with the highest number of out LGBTI MPs in the world.

Published
11 May 2015
From
Gay Star News
WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers

WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others.

Published
11 May 2015
From
World Health Organization
Glaxo drops plans to float 'gamechanging' HIV drugs arm, favouring in-house profits

The chief executive Andrew Witty declared prospects for its HIV drugs arm had improved dramatically in the past few months, thanks to a rapid increase in sales and some new forms of medicine being on the cusp of major breakthroughs.

Published
07 May 2015
From
The Independent
Glaxo Abandons HIV-Unit Spinoff Plan, Reduces Capital Payout

GlaxoSmithKline Plc shares rose as the U.K.’s biggest drug company abandoned plans to spin off its flourishing HIV-drugs unit and reduced funds to be returned to shareholders, retaining capital for bolstering growth. The decision to retain its full stake in ViiV Healthcare, an HIV joint venture with Pfizer Inc., reflects the unit’s “very positive outlook,” Glaxo said.

Published
06 May 2015
From
Bloomberg
US guidelines shift to integrase-based combinations for first-line treatment: Atripla relegated due to side effects

The rationale for dropping Atripla is due to concerns about the tolerability of efavirenz, especially the high rate of central nervous system related toxicities. Although this has been a long-standing community concern, DHHS guidelines have consistently recommended efavirenz in previous editions. This tolerability statement is made in the year that efavirenz comes off patent.

Published
06 May 2015
From
i-Base
Gilead: Stop Blocking Access to Hepatitis C Treatment

On the eve of pharmaceutical company Gilead Sciences’ annual shareholder meeting, thousands of people who have hepatitis C virus (HCV) and HCV/HIV coinfection, with their allies and physicians, have demanded that Gilead change its policies that deny access to treatment for millions of people in developing countries.

Published
05 May 2015
From
Treatment Action Group
Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry

Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment.

Published
05 May 2015
From
Hep C Coalition
Gilead’s Gaffe Leads Drugmakers to Pledge More Openness on Price

Drugmakers worried about a backlash over soaring drug prices are increasingly talking with insurers ahead of time about paying for new therapies that could cost six figures a year.

Published
05 May 2015
From
Bloomberg
Egypt opens first factory for locally produced Sovaldi

Egypt's health minister said Hepatitis C is "one of the most dangerous threats to Egypt", on Sunday during the opening ceremony of a factory for the local production of Hepatitis C medication Sovaldi.

Published
05 May 2015
From
News Egypt
Gilead first-quarter profit doubles on strong hepatitis C drug sales

Gilead Sciences Inc on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. Gilead signaled that, with its hepatitis C franchise established, it is a good time for the company to consider business development opportunities. "We want to stick very closely to therapeutic areas we are in today," Gilead Chief Operating Officer John Milligan said on a conference call.

Published
05 May 2015
From
Reuters

Filter by country